China Stem Cells Holdings Ltd.(CSC), one of only 3 operating cord blood banks approved by the Ministry of Health of China, owns and operates cord blood banking business in China.Its principal business activities include the provision of umbilical cord blood stem cells storage service, the provision of cord stem cells for clinical applications and the research and development of cellular therapies.

With its proven success in the Beijing region, the company plans to establish a nationwide blood stem cell storage network by expanding its services into Guangdong, Shandong, Zhejiang, Gansu, Xinjiang, Shanghai, Chongqing, Sichuan and Liaoning by 2010, the 11 affluent provinces and cities where the Group's cord blood banks will be located.

Beijing Jiachenghong Biotech Ltd., the subsidiary of CSC, was selected as 50 Fastest Growing High-tech Comapnies in China and 500 Fastest Growing High-tech Firms in Asia Pacific of the Year 2006 by Deloitte.